MX9203452A - Derivados de 2-(piperidin-1-il)-etanol, su preparacion y su aplicacion en terapeutica. - Google Patents

Derivados de 2-(piperidin-1-il)-etanol, su preparacion y su aplicacion en terapeutica.

Info

Publication number
MX9203452A
MX9203452A MX9203452A MX9203452A MX9203452A MX 9203452 A MX9203452 A MX 9203452A MX 9203452 A MX9203452 A MX 9203452A MX 9203452 A MX9203452 A MX 9203452A MX 9203452 A MX9203452 A MX 9203452A
Authority
MX
Mexico
Prior art keywords
therapeutics
enantiomers
piperidin
ethanol
derivatives
Prior art date
Application number
MX9203452A
Other languages
English (en)
Inventor
Corinne Rousselle
Jonathan Frost
Patrick Landenois
Maria Carmen Renones
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9107934A external-priority patent/FR2678265B1/fr
Priority claimed from FR9107936A external-priority patent/FR2678270B1/fr
Priority claimed from FR9204507A external-priority patent/FR2689891B3/fr
Application filed by Synthelabo filed Critical Synthelabo
Publication of MX9203452A publication Critical patent/MX9203452A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Compuesto bajo en forma de isómero puro o de mezcla de dos enantiómeros, de fórmula general (I). Se aplica en terapéutica. La molécula representada por la fórmula general (I) que tiene un átomo de carbono asimétrico los compuestos de la invención pueden existir bajo la forma de enantiómeros puros y de mezcla de enantiómeros. Finalmente, los compuestos de la invención pueden presentarse al estado de bases libres o de sales de adición a loa ácidos farmacéuticamente aceptables. Esas diferentes formas forman parte de la invención.
MX9203452A 1991-06-27 1992-06-26 Derivados de 2-(piperidin-1-il)-etanol, su preparacion y su aplicacion en terapeutica. MX9203452A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9107934A FR2678265B1 (fr) 1991-06-27 1991-06-27 Derives de 4-(2-phenylethyl)piperidine, leur preparation et leur application en therapeutique.
FR9107936A FR2678270B1 (fr) 1991-06-27 1991-06-27 Derives de 2-(piperidin-1-yl)ethanol, leur preparation et leur application en therapeutique.
FR9204507A FR2689891B3 (fr) 1992-04-13 1992-04-13 Derives de 2-(piperidin-1-yl)ethanol, leur preparation et leur application en therapeutique.

Publications (1)

Publication Number Publication Date
MX9203452A true MX9203452A (es) 1994-01-31

Family

ID=27252473

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9203452A MX9203452A (es) 1991-06-27 1992-06-26 Derivados de 2-(piperidin-1-il)-etanol, su preparacion y su aplicacion en terapeutica.

Country Status (14)

Country Link
EP (1) EP0524846A1 (es)
JP (1) JPH05186460A (es)
KR (1) KR930000505A (es)
CN (1) CN1069491A (es)
AU (1) AU644296B2 (es)
CA (1) CA2072520A1 (es)
CZ (1) CZ199992A3 (es)
FI (1) FI922979A (es)
HU (1) HUT61743A (es)
IE (1) IE922090A1 (es)
IL (1) IL102334A0 (es)
MX (1) MX9203452A (es)
NO (1) NO922521L (es)
NZ (1) NZ243337A (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994001403A1 (en) * 1992-07-08 1994-01-20 Shell Internationale Research Maatschappij B.V. Piperidine derivatives
NZ255074A (en) * 1992-10-30 1996-10-28 Pfizer 6-[2-(4-hydroxy-4-(4-substituted phenyl)piperidino)-1-hydroxypropyl]-3,4-dihydro-2(1h)-quinolones
FR2727864B1 (fr) * 1994-12-12 1997-04-04 Synthelabo Utilisation des ligands des sites de liaison peripherique pour les benzodiazepines pour la preparation de medicaments utiles dans le traitement des neuropathies peripheriques
ZA9610736B (en) * 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610738B (en) 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof
ZA9610741B (en) 1995-12-22 1997-06-24 Warner Lambert Co 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
FR2778564B1 (fr) * 1998-05-13 2001-07-13 Sanofi Sa Utilisation de composes reduisant l'apoptose
WO1999058117A1 (fr) * 1998-05-13 1999-11-18 Sanofi-Synthelabo Utilisation de composes reduisant l'apoptose
AU2185100A (en) 1998-12-18 2000-07-12 Scios Inc. Agonists and antagonists of peripheral-type benzodiazepine receptors
US20070185168A1 (en) * 2004-04-07 2007-08-09 Takai Haruki S Piperidine derivatives
CN103896835A (zh) * 2014-04-20 2014-07-02 武汉珈瑜科技有限公司 喹啉酮类衍生物及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1030415A (zh) * 1987-02-20 1989-01-18 山之内制药株式会社 饱和的杂环碳酰胺衍生物和它的制备方法
FR2640266B2 (fr) * 1988-07-12 1992-07-10 Synthelabo Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2, quinoleinones-2, benzo(b)azepinones-2 et benzimidazolones-2, leur preparation et leur application en therapeutique
JP2969359B2 (ja) * 1989-01-13 1999-11-02 武田薬品工業株式会社 環状アミン化合物
FR2644786B1 (fr) * 1989-03-21 1993-12-31 Adir Cie Nouveaux derives fluoro-4 benzoiques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
JPH03130263A (ja) * 1989-07-19 1991-06-04 Eisai Co Ltd 光学活性ナフチルエタノール誘導体
FR2668149B1 (fr) * 1990-10-18 1994-09-23 Synthelabo Le 1-(3,4-dihydro-2-oxo-1h-quinolein-6-yl)-2-[4-(2-phenyl-ethyl)piperidin-1-yl]ethanol, sa preparation et son application en therapeutique.

Also Published As

Publication number Publication date
EP0524846A1 (fr) 1993-01-27
FI922979A0 (fi) 1992-06-26
FI922979A (fi) 1992-12-28
HU9202138D0 (en) 1992-10-28
CZ199992A3 (en) 1993-01-13
NO922521L (no) 1992-12-28
HUT61743A (en) 1993-03-01
AU1858992A (en) 1993-01-07
JPH05186460A (ja) 1993-07-27
NO922521D0 (no) 1992-06-26
CN1069491A (zh) 1993-03-03
AU644296B2 (en) 1993-12-02
IE922090A1 (en) 1992-12-30
KR930000505A (ko) 1993-01-15
NZ243337A (en) 1994-03-25
CA2072520A1 (en) 1992-12-28
IL102334A0 (en) 1993-01-14

Similar Documents

Publication Publication Date Title
NO20071498L (no) Substituerte acylhydroksamsyrer samt fremgangsmate for a redusere TNFa-nivaet
MX9203452A (es) Derivados de 2-(piperidin-1-il)-etanol, su preparacion y su aplicacion en terapeutica.
PT96897A (pt) Processo para a preparacao de novos compostos aril-e heteroariletilenicos e de composicoes farmaceuticas que os contem
ES2055860T3 (es) Derivados 2-aminopirimidinona.
FI915136A0 (fi) Cykliska iminoderivat, dessa foereningar innehaollande laekemede och foerfarande foer deras framstaellning.
NO863253L (no) Fremgangsmaate for fremstilling av et vandig vaeskeformig preparat.
MX3217E (es) Procedimiento para la preparacion de derivados de propoxi -3,4- di hidro carbo estirilo substituidos
BR9503536A (pt) Composto processo para sua preparação seu uso e composição farmacêutica
HUP9901212A2 (hu) N,N-dialkil-N-[2-(3-alkoxi-fenoxi)-etil]-amin-származékok, az ezeket tartalmazó gyógyszerkészítmények és helyi érzéstelenítőkként való alkalmazásuk
NO177995C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 1,3-dioksanderivater
AR018675A1 (es) Derivados de 3-(2-oxo-[1,3¿i¿]bipirrolidinil-3-ilidenometil)-cefem, una composicion farmaceutica y el uso de los mismos para la manufactura de un medicamento.
DK447284A (da) Aminoderivater af 2-(n-(2,2,5,5-tetramethyl-3-pyrrolin-3-carbonyl)),deres fremstilling og anvendelse
SE7612308L (sv) Sett att framstella 2,6-dimetyl-3-metoxikarbonyl-4-(2'-nitrofenyl)-1,4-dihydropyridin-5-karbonsyraisobutylester samt anvendning derav som kprpmarterapertikum.
SE425395B (sv) Forfarande for framstellning av fenyl- eller bensylfosfonatestrar
GB1535855A (en) Diazarhodamine-lactones their manufacture and their use as dye intermediates for copying processes
ES543789A0 (es) Procedimiento de preparacion de nuevos derivados a-etilami- noetoxibencilalcoholicos con un grupo fenil sustituido en situacion a y de sus sales de adicion acida y amobica cua- ternaria
BR0208719A (pt) Uso de um composto
ECSP910725A (es) Procedimiento para preparar nuevos derivados de 4( 1h) quinolona
ES422085A1 (es) Procedimiento para preparar amino-acilanilidas primarias.
ES528460A0 (es) Procedimiento de preparacion de nuevos deridados de alfa-etibenzol con un grupo amino propanolico sustituido y sus sales de adicion acidas y amonicas cuaternarias.
PT84635B (pt) Processo para a preparacao de novas composicoes injectaveis estaveis contendo compostos antiemeticos derivados da 4-amino-5-cloro-n-{2-(dietilamino)-etil}- -2-{alcoxi substituido}- benzamida
AR000267A1 (es)
BR0012592A (pt) Composto, uso dos compostos, combinação, e, preparação farmacêutica para uso oral ou parenteral
DK128892A (da) Benzyletherderivater
ES440767A2 (es) Procedimiento para la preparacion de derivados de fenileti- lamina.